A study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the tumor ...

Background: Discordance between Epstein-Barr virus-encoded small RNA (EBER) and Epstein-Barr virus (EBV) DNA status has been observed in certain NPC patients. We aimed to elucidate the prognostic ...

Nasopharyngeal cancer refers to a relatively uncommon malignancy that begins in the nasopharynx—the upper section of the throat located behind the nose and above the back of the mouth. To understand ...

In southern China the incidence of nasopharyngeal carcinoma approaches 50 per 100,000 persons per year. 52 Nasopharyngeal carcinoma occurs sporadically in the United States and western Europe.

Researchers conducted the randomized phase 3 DIPPER trial at 11 centers in China, enrolling 450 patients with T4N1M0 or T1-4N2-3M0 nasopharyngeal carcinoma who had completed induction-concurrent ...

Additionally, the effectiveness of single-agent penpulimab-kcqx was determined in Study AK105-202. The study included 125 patients with unresectable or metastatic non-keratinizing NPC who had disease ...

The US Food and Drug Administration (FDA) has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal antibody, penpulimab-kcqx. The antibody is to treat adult ...